Principal Financial Group Inc 89bio, Inc. Transaction History
Principal Financial Group Inc
- $162 Billion
- Q1 2024
A detailed history of Principal Financial Group Inc transactions in 89bio, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 10,614 shares of ETNB stock, worth $80,666. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,614Holding current value
$80,666% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ETNB
# of Institutions
164Shares Held
89.1MCall Options Held
584KPut Options Held
1.17M-
Janus Henderson Group PLC London, X012.6MShares$95.8 Million0.08% of portfolio
-
Rtw Investments, LP New York, NY7.38MShares$56.1 Million1.38% of portfolio
-
Black Rock Inc. New York, NY6.64MShares$50.4 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.3MShares$47.9 Million3.14% of portfolio
-
State Street Corp Boston, MA5.54MShares$42.1 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $353M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...